TTK Healthcare (BOM:507747) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:507747 TTK Healthcare Ltd BOM:507747
76 GF Score
Price ₹1,160.40
GF Value ₹1,437.96
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is TTK Healthcare Other Current Receivables?

TTK Healthcare BOM:507747 +1.79% 76 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:507747 with a GF Score™ of 76/100 and a GF Value™ of ₹1,437.96 (Modestly Undervalued). The stock has 5 warning signs investors should review.

TTK Healthcare's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

TTK Healthcare's annual Other Current Receivables increased from Mar. 2024 (₹270.73 Mil) to Mar. 2025 (₹312.68 Mil) and increased from Mar. 2025 (₹312.68 Mil) to Mar. 2026 (₹365.37 Mil).

TTK Healthcare Other Current Receivables Related Terms

TTK Healthcare Other Current Receivables Historical Data

* Premium members only.

The historical data trend for TTK Healthcare's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTK Healthcare Other Current Receivables Chart

TTK Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.56 222.99 270.73 312.68 365.37

TTK Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 365.37 0.00
BOM:507747
76GF Score
TTK Healthcare Ltd BOM:507747
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTK Healthcare Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
TTK Healthcare (BOM:507747) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on TTK Healthcare and its competitors.
Is TTK Healthcare's Other Current Receivables too high?
TTK Healthcare's current Other Current Receivables is ₹0 Mil. Overall, TTK Healthcare has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Other Current Receivables compare to LLY and JNJ?
TTK Healthcare's Other Current Receivables of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on TTK Healthcare and its competitors. TTK Healthcare's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,437.96, compared to a current price of ₹1,160.40 — trading 19.3% below its estimated fair value. The current Other Current Receivables is ₹0 Mil. TTK Healthcare's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTK Healthcare (BOM:507747) Overvalued in 2026?

Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued. The current stock price of ₹1,160.40 is trading 19.3% below its estimated GF Value™ of ₹1,437.96. GuruFocus considers TTK Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:507747:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹1,437.96 vs. price of ₹1,160.40 (19.3% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TTK Healthcare Business Description

Other Exchanges TTKHLTCARE:India
Address No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
76GF Score

Get the complete analysis for BOM:507747

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,160.40
Price
₹1,437.96
GF Value